nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—Dexamethasone—ankylosing spondylitis	0.217	0.246	CbGbCtD
Terbinafine—CYP19A1—Betamethasone—ankylosing spondylitis	0.173	0.197	CbGbCtD
Terbinafine—PTGS1—Sulfasalazine—ankylosing spondylitis	0.109	0.124	CbGbCtD
Terbinafine—CYP19A1—Dexamethasone—ankylosing spondylitis	0.101	0.115	CbGbCtD
Terbinafine—CYP2C19—Prednisone—ankylosing spondylitis	0.0424	0.0482	CbGbCtD
Terbinafine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0338	0.0384	CbGbCtD
Terbinafine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0315	0.0358	CbGbCtD
Terbinafine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0264	0.0301	CbGbCtD
Terbinafine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0256	0.0291	CbGbCtD
Terbinafine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.022	0.025	CbGbCtD
Terbinafine—CYP3A4—Betamethasone—ankylosing spondylitis	0.022	0.025	CbGbCtD
Terbinafine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0217	0.0247	CbGbCtD
Terbinafine—CYP3A4—Prednisone—ankylosing spondylitis	0.0205	0.0233	CbGbCtD
Terbinafine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0201	0.0229	CbGbCtD
Terbinafine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0128	0.0145	CbGbCtD
Terbinafine—Eye disorder—Betamethasone—ankylosing spondylitis	0.000351	0.00291	CcSEcCtD
Terbinafine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000341	0.00283	CcSEcCtD
Terbinafine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000341	0.00283	CcSEcCtD
Terbinafine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000338	0.00281	CcSEcCtD
Terbinafine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000335	0.00278	CcSEcCtD
Terbinafine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000335	0.00277	CcSEcCtD
Terbinafine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000334	0.00277	CcSEcCtD
Terbinafine—Alopecia—Betamethasone—ankylosing spondylitis	0.000332	0.00275	CcSEcCtD
Terbinafine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000332	0.00275	CcSEcCtD
Terbinafine—Discomfort—Prednisolone—ankylosing spondylitis	0.00033	0.00273	CcSEcCtD
Terbinafine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00033	0.00273	CcSEcCtD
Terbinafine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000329	0.00273	CcSEcCtD
Terbinafine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000328	0.00272	CcSEcCtD
Terbinafine—Erythema—Betamethasone—ankylosing spondylitis	0.000327	0.00271	CcSEcCtD
Terbinafine—Erythema—Dexamethasone—ankylosing spondylitis	0.000327	0.00271	CcSEcCtD
Terbinafine—Malaise—Triamcinolone—ankylosing spondylitis	0.000325	0.0027	CcSEcCtD
Terbinafine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000325	0.00269	CcSEcCtD
Terbinafine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000325	0.00269	CcSEcCtD
Terbinafine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000324	0.00269	CcSEcCtD
Terbinafine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000323	0.00268	CcSEcCtD
Terbinafine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000322	0.00267	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00032	0.00265	CcSEcCtD
Terbinafine—Neutropenia—Methotrexate—ankylosing spondylitis	0.00032	0.00265	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000318	0.00263	CcSEcCtD
Terbinafine—Cough—Triamcinolone—ankylosing spondylitis	0.000315	0.00261	CcSEcCtD
Terbinafine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000312	0.00259	CcSEcCtD
Terbinafine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000307	0.00255	CcSEcCtD
Terbinafine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000306	0.00254	CcSEcCtD
Terbinafine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000306	0.00254	CcSEcCtD
Terbinafine—Eye disorder—Prednisone—ankylosing spondylitis	0.000306	0.00254	CcSEcCtD
Terbinafine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000305	0.00253	CcSEcCtD
Terbinafine—Infestation—Methotrexate—ankylosing spondylitis	0.000305	0.00253	CcSEcCtD
Terbinafine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000305	0.00253	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000304	0.00252	CcSEcCtD
Terbinafine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000304	0.00252	CcSEcCtD
Terbinafine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000304	0.00252	CcSEcCtD
Terbinafine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000303	0.00251	CcSEcCtD
Terbinafine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000303	0.00251	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000302	0.0025	CcSEcCtD
Terbinafine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.0003	0.00249	CcSEcCtD
Terbinafine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000299	0.00248	CcSEcCtD
Terbinafine—Angioedema—Betamethasone—ankylosing spondylitis	0.000299	0.00248	CcSEcCtD
Terbinafine—Angiopathy—Prednisone—ankylosing spondylitis	0.000297	0.00246	CcSEcCtD
Terbinafine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000296	0.00245	CcSEcCtD
Terbinafine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000296	0.00245	CcSEcCtD
Terbinafine—Malaise—Dexamethasone—ankylosing spondylitis	0.000295	0.00245	CcSEcCtD
Terbinafine—Malaise—Betamethasone—ankylosing spondylitis	0.000295	0.00245	CcSEcCtD
Terbinafine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000294	0.00244	CcSEcCtD
Terbinafine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000294	0.00244	CcSEcCtD
Terbinafine—Vertigo—Betamethasone—ankylosing spondylitis	0.000294	0.00244	CcSEcCtD
Terbinafine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000294	0.00243	CcSEcCtD
Terbinafine—Infection—Triamcinolone—ankylosing spondylitis	0.000292	0.00242	CcSEcCtD
Terbinafine—Infection—Methylprednisolone—ankylosing spondylitis	0.000292	0.00242	CcSEcCtD
Terbinafine—Alopecia—Prednisone—ankylosing spondylitis	0.000289	0.0024	CcSEcCtD
Terbinafine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000288	0.00239	CcSEcCtD
Terbinafine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000288	0.00239	CcSEcCtD
Terbinafine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000287	0.00238	CcSEcCtD
Terbinafine—Mental disorder—Prednisone—ankylosing spondylitis	0.000287	0.00238	CcSEcCtD
Terbinafine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000285	0.00236	CcSEcCtD
Terbinafine—Erythema—Prednisone—ankylosing spondylitis	0.000285	0.00236	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000284	0.00236	CcSEcCtD
Terbinafine—Myalgia—Betamethasone—ankylosing spondylitis	0.000279	0.00231	CcSEcCtD
Terbinafine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000279	0.00231	CcSEcCtD
Terbinafine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000278	0.0023	CcSEcCtD
Terbinafine—Anxiety—Betamethasone—ankylosing spondylitis	0.000278	0.0023	CcSEcCtD
Terbinafine—Discomfort—Betamethasone—ankylosing spondylitis	0.000275	0.00228	CcSEcCtD
Terbinafine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000275	0.00228	CcSEcCtD
Terbinafine—Pain—Prednisolone—ankylosing spondylitis	0.000274	0.00227	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000274	0.00227	CcSEcCtD
Terbinafine—Vision blurred—Prednisone—ankylosing spondylitis	0.000269	0.00223	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000268	0.00222	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000268	0.00222	CcSEcCtD
Terbinafine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000267	0.00221	CcSEcCtD
Terbinafine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000267	0.00221	CcSEcCtD
Terbinafine—Infection—Dexamethasone—ankylosing spondylitis	0.000265	0.0022	CcSEcCtD
Terbinafine—Infection—Betamethasone—ankylosing spondylitis	0.000265	0.0022	CcSEcCtD
Terbinafine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000264	0.00219	CcSEcCtD
Terbinafine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000264	0.00219	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000264	0.00219	CcSEcCtD
Terbinafine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000264	0.00219	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000264	0.00219	CcSEcCtD
Terbinafine—Anaemia—Prednisone—ankylosing spondylitis	0.000263	0.00218	CcSEcCtD
Terbinafine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000262	0.00217	CcSEcCtD
Terbinafine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000262	0.00217	CcSEcCtD
Terbinafine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000262	0.00217	CcSEcCtD
Terbinafine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000262	0.00217	CcSEcCtD
Terbinafine—Angioedema—Prednisone—ankylosing spondylitis	0.00026	0.00216	CcSEcCtD
Terbinafine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000259	0.00215	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000259	0.00214	CcSEcCtD
Terbinafine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000259	0.00214	CcSEcCtD
Terbinafine—Malaise—Prednisone—ankylosing spondylitis	0.000257	0.00213	CcSEcCtD
Terbinafine—Vertigo—Prednisone—ankylosing spondylitis	0.000256	0.00212	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000256	0.00212	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000255	0.00211	CcSEcCtD
Terbinafine—Anorexia—Betamethasone—ankylosing spondylitis	0.000255	0.00211	CcSEcCtD
Terbinafine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000255	0.00211	CcSEcCtD
Terbinafine—Urticaria—Prednisolone—ankylosing spondylitis	0.000254	0.00211	CcSEcCtD
Terbinafine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000254	0.0021	CcSEcCtD
Terbinafine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000253	0.0021	CcSEcCtD
Terbinafine—Pain—Triamcinolone—ankylosing spondylitis	0.000252	0.00209	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000248	0.00206	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000247	0.00205	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000243	0.00202	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000243	0.00202	CcSEcCtD
Terbinafine—Arthralgia—Prednisone—ankylosing spondylitis	0.000243	0.00201	CcSEcCtD
Terbinafine—Myalgia—Prednisone—ankylosing spondylitis	0.000243	0.00201	CcSEcCtD
Terbinafine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000243	0.00201	CcSEcCtD
Terbinafine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000242	0.00201	CcSEcCtD
Terbinafine—Anxiety—Prednisone—ankylosing spondylitis	0.000242	0.002	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—ankylosing spondylitis	0.000242	0.002	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000241	0.002	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00024	0.00199	CcSEcCtD
Terbinafine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00024	0.00199	CcSEcCtD
Terbinafine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00024	0.00199	CcSEcCtD
Terbinafine—Discomfort—Prednisone—ankylosing spondylitis	0.00024	0.00199	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00024	0.00199	CcSEcCtD
Terbinafine—Erythema—Methotrexate—ankylosing spondylitis	0.000238	0.00197	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000236	0.00195	CcSEcCtD
Terbinafine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000235	0.00195	CcSEcCtD
Terbinafine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000235	0.00195	CcSEcCtD
Terbinafine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000234	0.00194	CcSEcCtD
Terbinafine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000233	0.00193	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000233	0.00193	CcSEcCtD
Terbinafine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000233	0.00193	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000233	0.00193	CcSEcCtD
Terbinafine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000232	0.00192	CcSEcCtD
Terbinafine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000232	0.00192	CcSEcCtD
Terbinafine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000232	0.00192	CcSEcCtD
Terbinafine—Infection—Prednisone—ankylosing spondylitis	0.000231	0.00192	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000231	0.00191	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000231	0.00191	CcSEcCtD
Terbinafine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00023	0.00191	CcSEcCtD
Terbinafine—Fatigue—Betamethasone—ankylosing spondylitis	0.00023	0.00191	CcSEcCtD
Terbinafine—Pain—Betamethasone—ankylosing spondylitis	0.000228	0.00189	CcSEcCtD
Terbinafine—Pain—Dexamethasone—ankylosing spondylitis	0.000228	0.00189	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000228	0.00189	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—ankylosing spondylitis	0.000226	0.00187	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000224	0.00186	CcSEcCtD
Terbinafine—Anorexia—Prednisone—ankylosing spondylitis	0.000222	0.00184	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000221	0.00183	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—ankylosing spondylitis	0.00022	0.00182	CcSEcCtD
Terbinafine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00022	0.00182	CcSEcCtD
Terbinafine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00022	0.00182	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000218	0.00181	CcSEcCtD
Terbinafine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000218	0.00181	CcSEcCtD
Terbinafine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000217	0.0018	CcSEcCtD
Terbinafine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000216	0.00179	CcSEcCtD
Terbinafine—Malaise—Methotrexate—ankylosing spondylitis	0.000215	0.00178	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—ankylosing spondylitis	0.000214	0.00177	CcSEcCtD
Terbinafine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000212	0.00176	CcSEcCtD
Terbinafine—Urticaria—Betamethasone—ankylosing spondylitis	0.000212	0.00176	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000212	0.00176	CcSEcCtD
Terbinafine—Dizziness—Prednisolone—ankylosing spondylitis	0.000212	0.00175	CcSEcCtD
Terbinafine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000211	0.00175	CcSEcCtD
Terbinafine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000211	0.00175	CcSEcCtD
Terbinafine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000211	0.00175	CcSEcCtD
Terbinafine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000211	0.00175	CcSEcCtD
Terbinafine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000211	0.00175	CcSEcCtD
Terbinafine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000211	0.00175	CcSEcCtD
Terbinafine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000209	0.00173	CcSEcCtD
Terbinafine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000208	0.00173	CcSEcCtD
Terbinafine—Cough—Methotrexate—ankylosing spondylitis	0.000208	0.00172	CcSEcCtD
Terbinafine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000208	0.00172	CcSEcCtD
Terbinafine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000205	0.0017	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000203	0.00168	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—ankylosing spondylitis	0.000203	0.00168	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—ankylosing spondylitis	0.000203	0.00168	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000202	0.00168	CcSEcCtD
Terbinafine—Rash—Prednisolone—ankylosing spondylitis	0.000202	0.00167	CcSEcCtD
Terbinafine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000202	0.00167	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000201	0.00167	CcSEcCtD
Terbinafine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000201	0.00167	CcSEcCtD
Terbinafine—Fatigue—Prednisone—ankylosing spondylitis	0.000201	0.00166	CcSEcCtD
Terbinafine—Headache—Prednisolone—ankylosing spondylitis	0.000201	0.00166	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—ankylosing spondylitis	0.0002	0.00166	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—ankylosing spondylitis	0.000196	0.00162	CcSEcCtD
Terbinafine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000195	0.00161	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000194	0.00161	CcSEcCtD
Terbinafine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000194	0.00161	CcSEcCtD
Terbinafine—Infection—Methotrexate—ankylosing spondylitis	0.000193	0.0016	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000192	0.00159	CcSEcCtD
Terbinafine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000192	0.00159	CcSEcCtD
Terbinafine—Asthenia—Betamethasone—ankylosing spondylitis	0.000192	0.00159	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000191	0.00158	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00019	0.00158	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00019	0.00158	CcSEcCtD
Terbinafine—Nausea—Prednisolone—ankylosing spondylitis	0.00019	0.00158	CcSEcCtD
Terbinafine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000189	0.00157	CcSEcCtD
Terbinafine—Pruritus—Betamethasone—ankylosing spondylitis	0.000189	0.00157	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000189	0.00157	CcSEcCtD
Terbinafine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000187	0.00155	CcSEcCtD
Terbinafine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000187	0.00155	CcSEcCtD
Terbinafine—Rash—Triamcinolone—ankylosing spondylitis	0.000186	0.00154	CcSEcCtD
Terbinafine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000185	0.00154	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—ankylosing spondylitis	0.000185	0.00154	CcSEcCtD
Terbinafine—Rash—Methylprednisolone—ankylosing spondylitis	0.000185	0.00153	CcSEcCtD
Terbinafine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000185	0.00153	CcSEcCtD
Terbinafine—Urticaria—Prednisone—ankylosing spondylitis	0.000185	0.00153	CcSEcCtD
Terbinafine—Headache—Triamcinolone—ankylosing spondylitis	0.000184	0.00153	CcSEcCtD
Terbinafine—Headache—Methylprednisolone—ankylosing spondylitis	0.000184	0.00153	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000184	0.00152	CcSEcCtD
Terbinafine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000184	0.00152	CcSEcCtD
Terbinafine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000183	0.00151	CcSEcCtD
Terbinafine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000183	0.00151	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000177	0.00147	CcSEcCtD
Terbinafine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000177	0.00146	CcSEcCtD
Terbinafine—Dizziness—Betamethasone—ankylosing spondylitis	0.000177	0.00146	CcSEcCtD
Terbinafine—Nausea—Triamcinolone—ankylosing spondylitis	0.000175	0.00145	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000175	0.00145	CcSEcCtD
Terbinafine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000174	0.00145	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000171	0.00142	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000171	0.00142	CcSEcCtD
Terbinafine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00017	0.00141	CcSEcCtD
Terbinafine—Vomiting—Betamethasone—ankylosing spondylitis	0.00017	0.00141	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000169	0.0014	CcSEcCtD
Terbinafine—Rash—Betamethasone—ankylosing spondylitis	0.000168	0.0014	CcSEcCtD
Terbinafine—Rash—Dexamethasone—ankylosing spondylitis	0.000168	0.0014	CcSEcCtD
Terbinafine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000168	0.00139	CcSEcCtD
Terbinafine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000168	0.00139	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000168	0.00139	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—ankylosing spondylitis	0.000168	0.00139	CcSEcCtD
Terbinafine—Headache—Betamethasone—ankylosing spondylitis	0.000167	0.00139	CcSEcCtD
Terbinafine—Headache—Dexamethasone—ankylosing spondylitis	0.000167	0.00139	CcSEcCtD
Terbinafine—Asthenia—Prednisone—ankylosing spondylitis	0.000167	0.00138	CcSEcCtD
Terbinafine—Pain—Methotrexate—ankylosing spondylitis	0.000166	0.00138	CcSEcCtD
Terbinafine—Pruritus—Prednisone—ankylosing spondylitis	0.000165	0.00136	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00016	0.00133	CcSEcCtD
Terbinafine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000159	0.00132	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000159	0.00132	CcSEcCtD
Terbinafine—Nausea—Betamethasone—ankylosing spondylitis	0.000159	0.00131	CcSEcCtD
Terbinafine—Nausea—Dexamethasone—ankylosing spondylitis	0.000159	0.00131	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—ankylosing spondylitis	0.000154	0.00128	CcSEcCtD
Terbinafine—Dizziness—Prednisone—ankylosing spondylitis	0.000154	0.00127	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000154	0.00127	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000154	0.00127	CcSEcCtD
Terbinafine—Vomiting—Prednisone—ankylosing spondylitis	0.000148	0.00123	CcSEcCtD
Terbinafine—Rash—Prednisone—ankylosing spondylitis	0.000147	0.00122	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—ankylosing spondylitis	0.000147	0.00121	CcSEcCtD
Terbinafine—Headache—Prednisone—ankylosing spondylitis	0.000146	0.00121	CcSEcCtD
Terbinafine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000143	0.00119	CcSEcCtD
Terbinafine—Asthenia—Methotrexate—ankylosing spondylitis	0.000139	0.00116	CcSEcCtD
Terbinafine—Nausea—Prednisone—ankylosing spondylitis	0.000138	0.00115	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—ankylosing spondylitis	0.000138	0.00114	CcSEcCtD
Terbinafine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000133	0.0011	CcSEcCtD
Terbinafine—Dizziness—Methotrexate—ankylosing spondylitis	0.000129	0.00107	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—ankylosing spondylitis	0.000124	0.00102	CcSEcCtD
Terbinafine—Rash—Methotrexate—ankylosing spondylitis	0.000123	0.00102	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000122	0.00101	CcSEcCtD
Terbinafine—Headache—Methotrexate—ankylosing spondylitis	0.000122	0.00101	CcSEcCtD
Terbinafine—Nausea—Methotrexate—ankylosing spondylitis	0.000115	0.000957	CcSEcCtD
